Your browser doesn't support javascript.
loading
Efficacy and safety of switching to ixekizumab in secukinumab nonresponder patients with psoriasis: results from a multicentre experience.
Conti, A; Peccerillo, F; Amerio, P; Balato, A; Bardazzi, F; Bianchi, L; Burlando, M; Cannavò, S P; Chiricozzi, A; Dapavo, P; De Simone, C; Fargnoli, M C; Gambardella, A; Gisondi, P; Malagoli, P; Malara, G; Mugheddu, C; Offidani, A M; Piaserico, S; Prignano, F; Stingeni, L; Pellacani, G.
  • Conti A; Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy.
  • Peccerillo F; Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy.
  • Amerio P; Department of Medicine and Aging Science, Dermatologic Clinic, G. D'Annunzio University, Chieti, Italy.
  • Balato A; Department of Dermatology, University of Naples Federico II, Naples, Italy.
  • Bardazzi F; Department of Specialized, Clinical and Experimental Medicine, Division of Dermatology, University of Bologna, Bologna, Italy.
  • Bianchi L; Department of Dermatology, University of Rome Tor Vergata, Rome, Italy.
  • Burlando M; Section of Dermatology, University of Genoa, San Martino Polyclinic Hospital, Genoa, Italy.
  • Cannavò SP; Department of Clinical and Experimental Medicine - Dermatology, University of Messina, Messina, Italy.
  • Chiricozzi A; Department of Dermatology, University of Pisa, Pisa, Italy.
  • Dapavo P; Department of Biomedical Science and Human Oncology, Second Dermatologic Clinic, University of Turin, Turin, Italy.
  • De Simone C; Department of Dermatology, Catholic University of the Sacred Heart, Rome, Italy.
  • Fargnoli MC; Department of Dermatology, University of L'Aquila, L'Aquila, Italy.
  • Gambardella A; Dermatology Unit, University of Campania, Naples, Italy.
  • Gisondi P; Department of Medicine, Section of Dermatology and Venereology, University of Verona, Verona, Italy.
  • Malagoli P; Dermatology Unit, Azienda Ospedaliera San Donato Milanese, Milan, Italy.
  • Malara G; Dermatology Department, Grande Ospedale Metropolitano, Bianchi Melacrino Morelli, 89124, Reggio Calabria, Italy.
  • Mugheddu C; Department of Medical Sciences and Public Health, Section of Dermatology, University of Cagliari, Cagliari, Italy.
  • Offidani AM; Department of Clinical and Molecular Sciences, Dermatology Unit, Polytechnic Marche University, Ancona, Italy.
  • Piaserico S; Department of Dermatology, University of Padua, Padova, Italy.
  • Prignano F; Department of Dermatology, University of Florence, Firenze, Italy.
  • Stingeni L; Department of Medicine, Section of Clinical, Allergological and Venereological Dermatology, University of Perugia, Perugia, Italy.
  • Pellacani G; Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy.
Br J Dermatol ; 180(6): 1547-1548, 2019 06.
Article en En | MEDLINE | ID: mdl-30578668
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Psoriasis / Fármacos Dermatológicos / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Psoriasis / Fármacos Dermatológicos / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article